myhealthywaist.org - European Atherosclerosis Society (EAS)

CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

Events

European Atherosclerosis Society (EAS)

April 27, 2008 ISTANBUL, TURKEY

Abdominal Obesity and Global Cardiometabolic Risk

Room: Auditorium (Anitschkow Hall)
Time: 14 h 00 – 15 h 00
Chairpersons: L. Tokgözoglu, L. van Gaal

JOINT SESSION OF ICCR/EAS 2008
ABDOMINAL OBESITY AND GLOBAL CARDIOMETABOLIC RISK


Time	Event Description	Presenter
	Opening Remarks	L. Tokgözoglu, Turkey
	The Place of HDL–C in Global Cardiometabolic Risk	B. Brewer, USA
	The Atherogenic Dyslipidemia of Abdominal Obesity, Insulin Resistance and Global Cardiometabolic Risk	M.R. Taskinen, Finland
	Lifestyle of Abdominal Obesity and Related Cardiometabolic Risk: the Synergie Trial	J.P. Després, Canada
	Closing Remarks	L. van Gaal, Belgium

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.